This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
. Page versions: R5 R4B R4 R3
| Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
Raw JSON (canonical form + also see JSON Format Specification)
Dosage with a Pre-Condition - Alprazolam
{
"resourceType": "MedicationAdministration",
"id": "medadmin0311",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: completed</p><p><b>medication</b>: <a> </a></p><blockquote><p><b>code</b>: <span>Alprazolam 0.25mg Oral Tablet</span></p></blockquote><p><b>subject</b>: <a>Donald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><p><b>effective</b>: 16 Jan. 2015, 8:03:00 am --> 16 Jan. 2015, 12:03:00 pm</p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Patrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07</a></td></tr></table><p><b>reasonCode</b>: <span>Dysmenorrhea</span></p><p><b>request</b>: <a>Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; ?ngen-3; authoredOn: 2015-01-15</a></p><h3>Dosages</h3><table><tr><td>-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day</td><td><span>Oral Route</span></td><td>1 TAB</td></tr></table></div>"
},
"contained": [
{
"resourceType": "Medication",
"id": "med0304",
"code": {
"coding": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"code": "308047",
"display": "Alprazolam 0.25mg Oral Tablet"
}
]
}
}
],
"status": "completed",
"medicationReference": {
"reference": "#med0304"
},
"subject": {
"reference": "Patient/pat1",
"display": "Donald Duck"
},
"effectivePeriod": {
"start": "2015-01-15T22:03:00+01:00",
"end": "2015-01-16T02:03:00+01:00"
},
"performer": [
{
"actor": {
"reference": "Practitioner/f007",
"display": "Patrick Pump"
}
}
],
"reasonCode": [
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "266599000",
"display": "Dysmenorrhea"
}
]
}
],
"request": {
"reference": "MedicationRequest/medrx0305"
},
"dosage": {
"text": "0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015. Do not exceed more than 4mg per day",
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "26643006",
"display": "Oral Route"
}
]
},
"dose": {
"value": 1,
"unit": "TAB",
"system": "http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm",
"code": "TAB"
}
}
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.